Andere talen The Chemours Company

Aandelen

CC

US1638511089

Gediversifieerde chemicaliën

Beurs gesloten - Nyse Andere beurzen 21:00:02 14-03-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
14,40 ^USD	+5,11%		+1,98%	-14,79%

14/03	Chemours start proef met NTT DATA, Hibiya Engineering om technologie voor koeling van datacenters te testen	MT
14/03	Chemours bundelt krachten met NTT DATA en Hibiya Engineering, Ltd. voor grootschalige Opteon 2P50 producttest	RE

Andere talen

Chemours Joins Forces With NTT DATA and Hibiya Engineering, Ltd. for Full-Scale Opteon(TM) 2P50 Product Trial	14/03
Chemours Launches Trial With NTT DATA, Hibiya Engineering to Test Data Center Cooling Technology	14/03
Chemours Joins Forces With NTT DATA And Hibiya Engineering, Ltd. For Full-Scale Opteon 2P50 Product Trial	14/03
Chemours Joins Forces with NTT DATA and Hibiya Engineering, Ltd. For Full-Scale Opteon™ 2P50 Product Trial	14/03
Felician Sisters of North America Submits a Shareholder Proposal to The Chemours Company	10/03
The Chemours Company Announces Not to Seek Re-Election of Guillaume Pepy as Board of Directors	10/03
DoorDash, TKO, Williams-Sonoma Set to Join S&P 500	10/03
DoorDash, TKO Group Holdings, Williams-Sonoma And Expand Energy Set To Join S&P 500 Others To Join S&P 100, S&P Midcap 400 And S&P Smallcap 600	08/03
S&P Dow Jones Indices Doordash, Tko Group Holdings, Williams-Sonoma And Expand Energy Set To Join S&P 500	07/03
Chemours Launches Ti-Pure TS-6706, A TMP/TME- Free Version of Flagship Universal Grade, Ti-Pure R-706	20/02
Chemours Launches Ti-Pure™ TS-6706, A TMP/TME- Free Version of Flagship Universal Grade, Ti-Pure™ R-706	19/02
The Chemours Company Launches Ti-Pure TS-6706, A TMP/TME- Free Version of Universal Grade, Ti-Pure R-706	19/02
Stocks Rise Pre-Bell as Traders Await Fed Meeting Minutes; Asia Churns, Europe Mostly Up	18/02
Chemours : Earnings Presentation PDF (Chemours 4Q 2024 Earnings Supplement FINAL)	18/02
Chemours Q4 Adjusted Earnings, Revenue Decrease	18/02
Curtis V. Anastasio Do Not Seek for Re-Election to the Board of The Chemours Company	18/02
Chemours Outlook FY Adjusted EBITDA Between $825 Million And $975 Million	18/02
Chemours: Q4 Earnings Snapshot	18/02
Earnings Flash (CC) Chemours Co. Posts Q4 Revenue $1.36B, vs. FactSet Est of $1.37B	18/02
Earnings Flash (CC) Chemours Co. Posts Q4 Adjusted EPS $0.11, vs. FactSet Est of $0.12	18/02
The Chemours Company Reports Fourth Quarter and Full Year 2024 Results	18/02
The Chemours Company Reports Earnings Results for the Full Year Ended December 31, 2024	18/02
The Chemours Company Provides Earnings Guidance for the First Quarter of 2025	18/02
Chemours Keeps Quarterly Cash Dividend at $0.25 a Share, Payable March 14 to Holders as of Feb. 28	14/02
Chemours Announces First Quarter Dividend	14/02

23320789456f6cfe1c4b066b7da362d.fiEB_prpSYmIooX0I0jzc6p8J69JEGqF6x0ko5V55bs.R0BPs8uYLtzulcyrUwOVP8IXdec_PQnShSoc0sA9kMoqSmC4rtotwd-R3A

Word de lid om toegang te krijgen tot meer nieuws.

Gratis inschrijven

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen The Chemours Company

Aandelen

CC

US1638511089

Gediversifieerde chemicaliën

Andere talen

Filters